Clinical Trials Logo

Dermatitis clinical trials

View clinical trials related to Dermatitis.

Filter by:

NCT ID: NCT03492398 Completed - Atopic Dermatitis Clinical Trials

A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis

Shaperon
Start date: January 29, 2018
Phase: Phase 1
Study type: Interventional

A randomized, double-blind, placebo-controlled single and multiple dosing, dose escalation phase I clinical trial to investigate the safety/tolerability and pharmacokinetics of HY209 gel after transdermal administration in healthy male volunteers as a possible treatment option for atopic dermatitis

NCT ID: NCT03490877 Completed - Atopic Dermatitis Clinical Trials

Scratch and Sleep Quantification in Atopic Dermatitis

SQUAD
Start date: July 13, 2018
Phase:
Study type: Observational

Atopic dermatitis (AD) is a chronic type of eczema affecting approximately 10% of adults and 12% of children in the US. The intense itching (pruritus) associated with AD can be significantly disruptive to sleep and quality of life for both the patients and their caregivers. AD is challenging to describe and measure. The purpose of this study is to see if we can reliably measure how much people with AD scratch and how scratching interferes with sleep and quality of life by using digital sensors, sleep studies and patient-reported information.

NCT ID: NCT03490045 Completed - Stress Clinical Trials

Intervention to Reduce Diaper Need and Increase Use of Pediatric Preventive Care

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

Well-child care is the primary source of preventative health care for children. These visits provide an opportunity for physicians to assess an infant's biomedical health, development, and behavior, as well as help ensure timely immunizations, reduce the use of acute care services, and assess and family functioning. Yet, disparities in the utilization of pediatric care exist by race, ethnicity and income in the U.S., even despite high rates of overall access to primary care. Incentives have been proposed as one way to increase utilization of preventative care for mothers and children. Diapering is another important form of preventative health care that can be particularly difficult for low-income parents due the cost of diapers, which is $70-80 per child per month, or approximately $960 per year, on average. And government programs, such as Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), Supplemental Nutrition Assistance Program (SNAP), and Temporary Assistance for Needy Families (TANF), either cannot be used to purchase diapers, or do not provide enough assistance to cover the cost of diapers and other basic needs. A family's inability to provide an adequate supply of diapers for their child is called diaper need. Nationwide, one in three families with young children report experiencing diaper need, which was found to be significantly associated with maternal stress and depression, which in turn, can have a detrimental impact on a family's health and economic success. The primary goal of this study is to conduct a randomized controlled trial of a diaper provision intervention designed to increase utilization of, and adherence to, well-child visits and reduce diaper need among low-resourced families in New Haven, CT.

NCT ID: NCT03484897 Completed - Atopic Dermatitis Clinical Trials

Soothing and Barrier Restoration Activity of a Body Cream for Atopic Skin

Start date: January 12, 2018
Phase: N/A
Study type: Interventional

Open clinical study to evaluate the soothing activity of a body cream to be applied once a day, mono-laterally at level of the antecubital fold and forearm, for an uninterrupted period of 1 month, by 22 adult volunteers, with positive anamnesis for atopy and habitual itching.

NCT ID: NCT03483025 Completed - Clinical trials for Irritant Contact Dermatitis

Prospective Single Center Randomized Double Blind Controlled Tolerability Trial of Six Hair Cleansing Conditioners

Start date: April 4, 2018
Phase: N/A
Study type: Interventional

Hair cleansing product tolerability study

NCT ID: NCT03474874 Completed - Allergy Clinical Trials

Human Repeated Insult Patch Test

Start date: February 26, 2018
Phase: N/A
Study type: Interventional

Repeated insult patch test on healthy males and females to determine potential contact irritation or contact allergy in the skin

NCT ID: NCT03443024 Completed - Atopic Dermatitis Clinical Trials

A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis

Start date: January 30, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of lebrikizumab compared with placebo in participants with moderate-to-severe atopic dermatitis.

NCT ID: NCT03441568 Completed - Atopic Dermatitis Clinical Trials

In-home Use Test of the New Modified Diprobase Formulation to Assess the Safety and Tolerability in Infants and Children Under Physician's Control

Start date: September 26, 2018
Phase: N/A
Study type: Interventional

To investigate the safety and tolerability of the modified Diprobase formulation over 14 days in infants and children with a history of Atopic Dermatitis (AD).

NCT ID: NCT03435081 Completed - Atopic Dermatitis Clinical Trials

A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis

BREEZE-AD5
Start date: February 20, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis.

NCT ID: NCT03431610 Completed - Atopic Dermatitis Clinical Trials

A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic Dermatitis

Start date: November 13, 2017
Phase: Phase 1
Study type: Interventional

This is a Phase 1b, 2-week study assessing the pharmacokinetics, pharmacodynamics, safety and tolerability of SB414 in subjects with mild to moderate AD.